Biomarkers from Secondary Complications in Spinal Cord Injury

Author:

Alostaz Hani,Cai LiORCID

Publisher

Springer Science and Business Media LLC

Subject

Drug Discovery,Pharmacology,Genetics,Biochemistry

Reference54 articles.

1. Ahuja CS, Nori S, Tetreault L, Wilson J, Kwon B, Harrop J, et al. Traumatic spinal cord injury-repair and regeneration. Neurosurgery. 2017;80(3S):S9–22. https://doi.org/10.1093/neuros/nyw080.

2. •• Albayar AA, Roche A, Swiatkowski P, Antar S, Ouda N, Emara E, et al. Biomarkers in spinal cord injury: prognostic insights and future potentials. Front Neurol. 2019;10:27. https://doi.org/10.3389/fneur.2019.00027. This article provides a review of traumatic spinal cord injury in terms of consequences and its long term outlook. This article also describes common complications of SCI as well.

3. Leister I, Haider T, Mattiassich G, Kramer JLK, Linde LD, Pajalic A, et al. Biomarkers in traumatic spinal cord injury-technical and clinical considerations: a systematic review. Neurorehabil Neural Repair. 2020;34(2):95–110. https://doi.org/10.1177/1545968319899920.

4. • Wong KR, Mychasiuk R, O’Brien TJ, Shultz SR, McDonald SJ, Brady RD. Neurological heterotopic ossification: novel mechanisms, prognostic biomarkers and prophylactic therapies. Bone Res. 2020;8(1):42. https://doi.org/10.1038/s41413-020-00119-9. This article discusses NHO as a complication in that it provides a background and multiple viable biomarkers. This article also provides a recommendation for a therapeutic target to decrease NHO.

5. •• Alexander KA, Tseng HW, Fleming W, Jose B, Salga M, Kulina I, et al. Inhibition of JAK1/2 tyrosine kinases reduces neurogenic heterotopic ossification after spinal cord injury. Front Immunol. 2019;10:377. https://doi.org/10.3389/fimmu.2019.00377. This article provides a detailed explanation of causes for NHO. The article also describes therapeutic targets that could be further studied in order to mitigate this particular complication.

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3